Rejuve Meds review
The label says Most Affordable and the figure under it needs twelve months paid up front.
The verdict
Rejuve Meds shows $165 a month for compounded semaglutide, which its own footnote ties to a twelve-month plan paid upfront. The FAQ's ongoing range starts at $205, and it names no tirzepatide injection figure at all.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $205/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Rejuve Meds sells both molecules by injection, labeling the semaglutide line Most Affordable and pricing it on a plan a reader has to read a footnote to identify.
Who writes the prescription, and what do they see?
A prescription precedes shipping and the clinician is not described. Free shipping is stated, which is a smaller disclosure than the one missing about what an ongoing month costs.
A superlative label sitting on a prepaid figure is the shape to notice. Most Affordable describes the card, and the card describes a year paid in advance rather than a rate anyone is billed monthly.
What happens when the dose goes up?
Nothing states what the figure does at a higher dose. The FAQ's ongoing range runs from $205 to $399, which may reflect dose or may reflect product, and the site does not say which.
What the price includes
The twelve-month prepaid figure is $165 and the ongoing range starts at $205, so a reader paying monthly should plan from the higher number. An introductory first month from $85 is offered and a $120 summer discount is described as automatically applied. On tirzepatide the card reads $265 under the same prepaid footnote, and because the FAQ's range names no injection figure for it, no tirzepatide rate is published here.
What it claims, and what it cites
Both lines are compounded rather than manufactured, prepared by a pharmacy the site does not name, and not reviewed by the FDA before dispensing as an approved product is.
Where it holds up, and where it does not
- Strength: The prepaid footnote is present
- Strength: An ongoing range is published at all
- Strength: Free shipping and an intro month stated
- Limitation: The card figure needs twelve months upfront
- Limitation: The ongoing rate starts $40 higher
- Limitation: No tirzepatide monthly figure is published
- Limitation: The range's driver is not explained
What the evidence says about this kind of treatment
The assessment above is about Rejuve Meds. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who will prepay a year and has read the footnote under the label.
- Wrong for
- A reader planning to pay month to month from the card figure.
The evidence behind what Rejuve Meds prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Rejuve Meds compares
| Seller | Who it suits | Go |
|---|---|---|
 Regenics | Readers who will add the membership to the medication before comparing anything | See Regenics → |
| Remote Pharmacy | Readers prepared to get the billing term confirmed in writing before paying anything | See Remote Pharmacy → |
 Remedy Meds | Readers willing to finish the quiz who count the fills rather than the months | See Remedy Meds → |
More GLP-1 telehealth sellers reviews: FitishFitness RXFitRxFitstryFMmedsFORM
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is $165 a monthly rate?
- It is tied to a twelve-month plan paid upfront by the site's own footnote. The FAQ's ongoing range starts at $205.
- What does tirzepatide cost monthly?
- Not established. The card shows $265 under the same prepaid footnote, and the FAQ's ongoing range names no figure for the tirzepatide injection.
- What is the ongoing range?
- $205 to $399, without the site stating whether the spread reflects dose, product or plan.
- Is Rejuve Meds expensive compared with other GLP-1 telehealth sellers?
- Rejuve Meds publishes a starting figure of $205/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Rejuve Meds above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.